Literature DB >> 1448786

Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity.

L V Rao1, J F Tait, A D Hoang.   

Abstract

Proteins of the annexin/lipocortin family bind tightly to anionic phospholipids and platelets and act as in vitro anticoagulants. Annexins may be useful as tools to study the availability of anionic phospholipids on cell surfaces and their role in the regulation of blood coagulation. In the present study, we investigated the binding of annexin V (placental anticoagulant protein I) to a human ovarian carcinoma cell line, OC-2008, that constitutively expresses surface membrane tissue factor activity. Binding of annexin V to cell monolayers was calcium-dependent, specific, saturable and reversible; Scatchard analysis indicated a single class of binding sites with an apparent Kd of 9.4 +/- 3.1 nM and 5.2 +/- 1 x 10(6) sites per cell. Binding was completely inhibited by phospholipid vesicles containing phosphatidylserine, but was not inhibited by vesicles containing phosphatidylcholine. Annexin V inhibited the cell surface-dependent activity of prothrombinase complex, but did not inhibit the activity of the factor VIIa/tissue factor complex. In conclusion, these results suggest that anionic phospholipid is present on the extracellular face of OC-2008 cells; this anionic phospholipid is functionally important for the activity of the prothrombinase complex, but the importance of anionic phospholipid for the cell surface factor VIIa/tissue factor functional activity is unclear.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448786     DOI: 10.1016/0049-3848(92)90013-z

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  27 in total

Review 1.  Apoptosis-detecting radioligands: current state of the art and future perspectives.

Authors:  Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-12       Impact factor: 9.236

2.  Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47.

Authors:  Mark P Chao; Siddhartha Jaiswal; Rachel Weissman-Tsukamoto; Ash A Alizadeh; Andrew J Gentles; Jens Volkmer; Kipp Weiskopf; Stephen B Willingham; Tal Raveh; Christopher Y Park; Ravindra Majeti; Irving L Weissman
Journal:  Sci Transl Med       Date:  2010-12-22       Impact factor: 17.956

3.  Evidence for specific annexin I-binding proteins on human monocytes.

Authors:  N J Goulding; L Pan; K Wardwell; V C Guyre; P M Guyre
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

4.  HFIP extraction followed by 2D CTAB/SDS-PAGE separation: a new methodology for protein identification from tissue sections after MALDI mass spectrometry profiling for personalized medicine research.

Authors:  Rémi Longuespée; Christophe Tastet; Annie Desmons; Olivier Kerdraon; Robert Day; Isabelle Fournier; Michel Salzet
Journal:  OMICS       Date:  2014-05-19

5.  Measurement of the binding parameters of annexin derivative-erythrocyte membrane interactions.

Authors:  Tzu-Chen Yen; Shiaw-Pyng Wey; Chang-Hui Liao; Chi-Hsiao Yeh; Duan-Wen Shen; Samuel Achilefu; Tze-Chein Wun
Journal:  Anal Biochem       Date:  2010-07-01       Impact factor: 3.365

Review 6.  Imaging and therapeutic applications of zinc(ii)-dipicolylamine molecular probes for anionic biomembranes.

Authors:  Douglas R Rice; Kasey J Clear; Bradley D Smith
Journal:  Chem Commun (Camb)       Date:  2016-07-07       Impact factor: 6.222

Review 7.  Tissue factor encryption and decryption: facts and controversies.

Authors:  L Vijaya Mohan Rao; Hema Kothari; Usha R Pendurthi
Journal:  Thromb Res       Date:  2012-03-06       Impact factor: 3.944

8.  Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol.

Authors:  Samir K Mandal; Alexei Iakhiaev; Usha R Pendurthi; L Vijaya Mohan Rao
Journal:  Blood       Date:  2004-08-24       Impact factor: 22.113

9.  Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus.

Authors:  David A Coil; A Dusty Miller
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells.

Authors:  Bodil Fadnes; Oystein Rekdal; Lars Uhlin-Hansen
Journal:  BMC Cancer       Date:  2009-06-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.